Pfizer Consumer Healthcare Revenue Is “On Plan,” McKinnell Says
This article was originally published in The Rose Sheet
Executive Summary
Pfizer's Consumer Healthcare unit is doing "just fine" despite a 5% decrease in first quarter sales, CEO Hank McKinnell said during an April 19 earnings call
You may also be interested in...
Pfizer Values Standalone Consumer Unit At $10 Bil.
Pfizer is unlikely to divest individual brands from its Consumer Healthcare portfolio, leaving on the table the options of cashing out, spinning off or keeping the division, CEO Hank McKinnell indicated during a Feb. 10 analyst presentation
OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program
Beauty Claims Inch Closer To Pharma As Cosmeceutical Sector Expands
Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle